A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

NCT06230523 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight and Obesity

Interventions

DRUG: LY3841136
DRUG: Placebo

Sponsor

Eli Lilly and Company